364 related articles for article (PubMed ID: 35979165)
1. Patient-derived organoids for therapy personalization in inflammatory bowel diseases.
Lucafò M; Muzzo A; Marcuzzi M; Giorio L; Decorti G; Stocco G
World J Gastroenterol; 2022 Jun; 28(24):2636-2653. PubMed ID: 35979165
[TBL] [Abstract][Full Text] [Related]
2. Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases.
Yoo JH; Donowitz M
World J Gastroenterol; 2019 Aug; 25(30):4125-4147. PubMed ID: 31435168
[TBL] [Abstract][Full Text] [Related]
3. Modeling Inflammatory Bowel Disease by Intestinal Organoids.
Di Giorgio C; Roselli R; Biagioli M; Bordoni M; Ricci P; Zampella A; Distrutti E; Donini A; Fiorucci S
Recent Adv Inflamm Allergy Drug Discov; 2023; 17(1):39-53. PubMed ID: 36411558
[TBL] [Abstract][Full Text] [Related]
4. Organoid Medicine for Inflammatory Bowel Disease.
Wakisaka Y; Sugimoto S; Sato T
Stem Cells; 2022 Mar; 40(2):123-132. PubMed ID: 35258629
[TBL] [Abstract][Full Text] [Related]
5. Development of Physiologically Responsive Human iPSC-Derived Intestinal Epithelium to Study Barrier Dysfunction in IBD.
Gleeson JP; Estrada HQ; Yamashita M; Svendsen CN; Targan SR; Barrett RJ
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093254
[TBL] [Abstract][Full Text] [Related]
6. Potential Use of Human Stem Cell-Derived Intestinal Organoids to Study Inflammatory Bowel Diseases.
Dotti I; Salas A
Inflamm Bowel Dis; 2018 Nov; 24(12):2501-2509. PubMed ID: 30169820
[TBL] [Abstract][Full Text] [Related]
7. Potential Application of Intestinal Organoids in Intestinal Diseases.
Liu W; Wang Q; Bai Y; Xiao H; Li Z; Wang Y; Wang Q; Yang J; Sun H
Stem Cell Rev Rep; 2024 Jan; 20(1):124-137. PubMed ID: 37938407
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Intestinal Epithelial Barrier Function in Inflammatory Bowel Diseases Using Murine Intestinal Organoids.
Rallabandi HR; Yang H; Oh KB; Lee HC; Byun SJ; Lee BR
Tissue Eng Regen Med; 2020 Oct; 17(5):641-650. PubMed ID: 32594459
[TBL] [Abstract][Full Text] [Related]
9. Generation of hiPSC-Derived Intestinal Organoids for Developmental and Disease Modelling Applications.
Durczak PM; Fair KL; Jinks N; Cuevas Ocaña S; Sainz Zuñiga CB; Hannan NRF
J Vis Exp; 2024 Mar; (205):. PubMed ID: 38526083
[TBL] [Abstract][Full Text] [Related]
10. Challenges and opportunities in inflammatory bowel disease: from current therapeutic strategies to organoid-based models.
Kong L; Chen S; Huang S; Zheng A; Gao S; Ye J; Hua C
Inflamm Res; 2024 Apr; 73(4):541-562. PubMed ID: 38345635
[TBL] [Abstract][Full Text] [Related]
11. Generation of human colon organoids from healthy and inflammatory bowel disease mucosa.
Dotti I; Mayorgas A; Salas A
PLoS One; 2022; 17(10):e0276195. PubMed ID: 36301950
[TBL] [Abstract][Full Text] [Related]
12. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
13. Harnessing the Biology of Canine Intestinal Organoids to Heighten Understanding of Inflammatory Bowel Disease Pathogenesis and Accelerate Drug Discovery: A One Health Approach.
Kopper JJ; Iennarella-Servantez C; Jergens AE; Sahoo DK; Guillot E; Bourgois-Mochel A; Martinez MN; Allenspach K; Mochel JP
Front Toxicol; 2021; 3():773953. PubMed ID: 35295115
[TBL] [Abstract][Full Text] [Related]
14. Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers for Modeling Epithelial Barrier.
Jelinsky SA; Derksen M; Bauman E; Verissimo CS; van Dooremalen WTM; Roos JL; Higuera Barón C; Caballero-Franco C; Johnson BG; Rooks MG; Pott J; Oldenburg B; Vries RGJ; Boj SF; Kasaian MT; Pourfarzad F; Rosadini CV
Inflamm Bowel Dis; 2023 Feb; 29(2):195-206. PubMed ID: 36356046
[TBL] [Abstract][Full Text] [Related]
15. Application of Human Induced Pluripotent Stem Cell-Derived Intestinal Organoids as a Model of Epithelial Damage and Fibrosis in Inflammatory Bowel Disease.
Onozato D; Akagawa T; Kida Y; Ogawa I; Hashita T; Iwao T; Matsunaga T
Biol Pharm Bull; 2020; 43(7):1088-1095. PubMed ID: 32612071
[TBL] [Abstract][Full Text] [Related]
16. Human intestinal organoids: Modeling gastrointestinal physiology and immunopathology - current applications and limitations.
Flood P; Hanrahan N; Nally K; Melgar S
Eur J Immunol; 2024 Feb; 54(2):e2250248. PubMed ID: 37957831
[TBL] [Abstract][Full Text] [Related]
17. Molecular Manipulations and Intestinal Stem Cell-Derived Organoids in Inflammatory Bowel Disease.
Boye TL; Steenholdt C; Jensen KB; Nielsen OH
Stem Cells; 2022 May; 40(5):447-457. PubMed ID: 35365825
[TBL] [Abstract][Full Text] [Related]
18. Targeting uPA-uPAR interaction to improve intestinal epithelial barrier integrity in inflammatory bowel disease.
Cheng Y; Hall TR; Xu X; Yung I; Souza D; Zheng J; Schiele F; Hoffmann M; Mbow ML; Garnett JP; Li J
EBioMedicine; 2022 Jan; 75():103758. PubMed ID: 34933179
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Potential of Human Intestinal Organoids in Tissue Repair Approaches in Inflammatory Bowel Diseases.
Rutherford D; Ho GT
Inflamm Bowel Dis; 2023 Sep; 29(9):1488-1498. PubMed ID: 37094358
[TBL] [Abstract][Full Text] [Related]
20. Generation of Budding-Like Intestinal Organoids from Human Induced Pluripotent Stem Cells.
Onozato D; Ogawa I; Kida Y; Mizuno S; Hashita T; Iwao T; Matsunaga T
J Pharm Sci; 2021 Jul; 110(7):2637-2650. PubMed ID: 33794275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
